About hyperCORE International
Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. It is an industry leader, providing Phase I-IV clinical trial services with more than 90 active research sites across the globe. It is the second-largest clinical research site organization globally. Its member companies have over 100 years of combined experience and have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 15,000,000 patients. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.
hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup and enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.
hyperCORE and its partner members look to elevate the highly fragmented and inherently inefficient site model – something each member has already done on a singular level will now be achieved on a much larger scale. By combining their strengths and through further integration, the alliance is sure to turn
some heads. The alliance has more than 90 sites across 2 continents.
hyperCORE Partner members include: AGA Clinical Trials in Hialeah, FL; Benchmark Research of Austin, TX; Clinical Trials of Texas of San Antonio, TX; Clinical Site Partners of Winter Park, FL; DIEX Recherche of Sherbrooke, Canada; FOMAT Medical Research of Oxnard, CA; IACT Health of Columbus, GA; LMC Manna Research of Toronto, Canada; and Quality Clinical Research of Omaha, NE.
hyperCORE International: Officers
Karri Venn brings over 22 years of clinical research experience working at LMC Manna Research. Ms. Venn has brought experience, knowledge and drive to many of the positions held at LMC Healthcare. In 2006, Ms. Venn was promoted to Director, Research of LMC Clinical Research and subsequently in 2015 to President, Research of LMC Manna Research with a key responsibility of integration of Manna with LMC clinical sites to create the largest clinical community research site network in Canada. In total, there are 20 sites that include therapeutic expertise in all phases of research including real world/big data.
Ms. Venn has led the project management teams for > 1500 clinical trials and led the response to > 50 Sponsor & Regulatory audits. LMC Manna has become a reputable program and has received the distinct award as a Centre of Excellence in Diabetes clinical research, PRIME status with IQVIA, awarded in the Top 50 Great Places to Work for Canada and SPRIA winners at the 2017 SCRS conference. A founding member of hyperCORE International a leading Super Network of clinical sites which comprises of 80 sites, 5 countries and 9 site networks.
Ms. Venn has been certified in project management through the Project Management Institute, as well as longstanding certification as a Clinical Research Coordinator and Diabetes Educator.
Today, she is a founding Board member of the Canadian Association of Independent Clinical Research Sites (CAICR), hyperCORE International and great supporter of both Society for Clinical Research Sites (SCRS) & Association of Clinical Research Professionals (ACRP).
Dr. Jeff Kingsley
Dr. Kingsley received his Bachelor of Science degree from the University of Scranton in 1995 with concentrations in biology, chemistry, history, and cultural anthropology, and his Master of Science degree in 1997 in biochemistry. His medical degree was received from the Philadelphia College of Osteopathic Medicine in 2001 and his MBA was received from Emory University’s Goizueta Business School in 2011.
Dr. Kingsley has been faculty with the Columbus Regional Health Family Medicine Residency as well as Director of Family Medicine and Urgent Care. He currently holds faculty appointments with the Mercer School of Medicine and the Philadelphia College of Osteopathic Medicine Georgia.
Dr. Kingsley is founder and CEO of IACT Health, a research management organization, and 15 wholly owned and integrated clinical research offices in multiple cities in two states. The family of companies conduct phase Ib through IV research in nearly every medical specialty; inpatient and outpatient; pharmaceutical, biotechnology, and medical device. He has dedicated his career to clinical research since 2006.
Dr. Kingsley is the current COO and Chair of the Board of Directors of hyperCORE International, LLP, “Centers of Research Excellence”. IACT Health is one of eight companies partnered to form a new super network of highly experienced and awarded clinical research sites called hyperCORE International. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.
He is also the past Chair of the Board of Trustees for the Association for Clinical Research Professionals which represents more than 13,000 clinical research professionals internationally. He is the former Treasurer for ACRP and APCR, Past President of ABSAME, sits on three additional Boards, and participates on numerous other local, national, and international committees. Dr. Kingsley obtained his CPI in 2009 and his FACRP in 2017.
He enjoys each day with his wife Christine and four beautiful children.
Dr. Roberto Aguirre
Chief Medical Officer
Dr. Roberto Aguirre CPI, CCRP received his medical degree from “Universidad Catolica Santiago de Guayaquil” in 2001 and his CPI certification from ACRP in 2013.
Dr. Aguirre is the Founder and VP of AGA Clinical Trials since 2007, an International Research Organization with sites in Miami, FL and Ecuador, South America which conducts Phase I through IV research in Multiple Medical Specialties; Inpatient/Outpatient Services; Pharmaceutical, Biotechnology, and Medical Devices. He has dedicated his career to clinical research since 2004.
Dr.Aguirre has collaborated in different functions in over 200 research trials in pediatric and adult populations thanks to a team of prolific investigators, business partners, and research personnel.
Dr. Aguirre is the current CMO of the Board of Directors of hyperCORE International, LLP, “Centers of Research Excellence”. AGA CLINICAL TRIALS is one of 9 companies partnered to form a new super network of highly experienced and awarded clinical research sites called hyperCORE International. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.
Chairman of the Board
Mark Lacy is founder and CEO of Benchmark Research – a growing and dynamic firm with a network of quality investigative research sites throughout the United States. Mr. Lacy’s active participation with the Association of Clinical Research Professionals (ACRP) has encompassed serving as Chair of the Site Manager’s Forum, Chair of the Finance Committee, being elected to the Board of Trustees; and in 2005 being honored as a recipient of the Meritorious Service Award. Mr. Lacy also serves on the Board of Advisors for The Center for Information & Study on Clinical Research Participation (CISCRP), and as a member of the Executive Committee for the PharmaTimes U.S. Clinical Researcher of the Year competition.
In 2010, Mr. Lacy was selected by Entrepreneur Magazine as one of the top four “Established Entrepreneurs” for his success in growing Benchmark Research, and was recognized in 2011 by PharmaVoice as one of the 100 most Inspiring People. This entrepreneurial approach has extended into his formation of VaxCorps, a nationally prominent research network focusing on vaccines, of which he is the CEO. He is also emerging as a leader in real estate development in Texas with office buildings in Austin and ocean front resort properties on the Texas coast.
Prior to founding Benchmark Research, Mr. Lacy earned a B.A. degree from The University of Texas at Austin (Plan II Program, Summa Cum Laude); and held several prominent positions in state and national politics, including service under a Presidential Administration.